Concizumab (haemophilia A); Benefit assessment according to §35a SGB V
Fields of Study & Subjects
Hemophilia Treatment and Research
Platelet Disorders and Treatments
Health Systems
Economic Evaluations
Quality of Life
Publication details
- Journal / source
- Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
- Publication date
- 28 January 2026
- Language
- EN